Expert sees more diagnostic, therapeutic use for nanoparticle imaging

12/2/2008 | HealthImaging.com

Recent research advances have enabled scientists to bind nanoparticles to radionuclides for MR, SPECT, PET and near-infrared optical imaging to detect inflammation or certain ailments, said Michael J. Welch, a nuclear medicine expert. He said nanoparticles will help bring a new era of diagnostic imaging and personalized medicine. The initial clinical use of nanoparticle-based agents will be for cardiac problems, Welch predicted.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN